Kolinsky, M., Rescigno, P., Bianchini, D., Zafeiriou, Z., Mehra, N., Mateo, J., . . . de Bono, J. (2020). A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer. Ann Oncol.
Chicago-tyylinen lähdeviittausKolinsky, M.P., et al. "A Phase I Dose-escalation Study of Enzalutamide in Combination With The AKT Inhibitor AZD5363 (capivasertib) in Patients With Metastatic Castration-resistant Prostate Cancer." Ann Oncol 2020.
MLA-viiteKolinsky, M.P., et al. "A Phase I Dose-escalation Study of Enzalutamide in Combination With The AKT Inhibitor AZD5363 (capivasertib) in Patients With Metastatic Castration-resistant Prostate Cancer." Ann Oncol 2020.